Company Filing History:
Years Active: 2002-2007
Title: Innovations in Antitumor Therapy: The Work of Raymond W. Klecker, Jr.
Introduction
Raymond W. Klecker, Jr. is a notable inventor based in Silver Spring, MD, whose contributions to the field of pharmacology and medical imaging have led to significant advancements in antitumor therapies. With a total of 9 patented inventions, his work demonstrates a commitment to improving cancer treatment methodologies through innovative applications of science and technology.
Latest Patents
Among his latest patents, Raymond Klecker has developed a method for imaging drug accumulation, which serves as a guide to antitumor therapy. This groundbreaking invention employs radio-labeled antitumor drugs in the treatment of solid tumors. The technique involves administering a radio-labeled anticancer drug to a patient and subsequently imaging a part of the patient's body using Positron Emission Tomography (PET) imaging. This approach can not only monitor the delivery of antitumor drugs to tumors but also predict the effectiveness of therapy with specific drugs or combinations. Furthermore, it assists in assessing the efficacy of modulators of cellular accumulation, personalizing therapy for patients, and evaluating the effectiveness of antitumor drugs against specific cancers. Noteworthy drugs in this invention include radio-labeled taxanes such as C-paclitaxel and C-docetaxel, as well as labeled anthracyclines like C-doxorubicin and C-epirubicin.
Career Highlights
Klecker's career encompasses significant collaborations with esteemed organizations, notably the Department of Health and Human Services. His work within the United States government reflects a dedication to enhancing public health through innovative chemotherapy techniques. The patent applications stemming from his research have contributed to the ongoing dialogue surrounding effective cancer treatment strategies.
Collaborations
Throughout his career, Raymond W. Klecker, Jr. has worked alongside prominent colleagues such as Jerry M. Collins and Lawrence W. Anderson. Their collaborative efforts have resulted in a synergistic exchange of ideas, which has ultimately propelled forward the effectiveness of cancer treatments based on Klecker's innovative methodologies.
Conclusion
In conclusion, Raymond W. Klecker, Jr. stands out as a prolific inventor whose work has significantly impacted the field of oncology. With his innovative approaches to imaging drug accumulation and personalized therapy, he has opened new avenues for treating solid tumors. The insights gained from his patents not only enhance the understanding of drug interactions but also pave the way for more effective cancer therapies in the future.